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ABSTRACT 
Daniel P. Wilhite 
The Role of Expiratory Flow Limitation On the Oxygen Cost of Exercise Hyperpnea in Highly-
Trained Distance Runners 
There is an upper limitation to the flow rates achievable during exhalation.  Once this 
limitation is reached (expiratory flow limitation; FLexp), such as that observed during intensive 
exercise, no further increase in expiratory flow is possible. During heavy to maximal exercise, a 
major consequence of FLexp may be an increased oxygen cost of breathing. To examine the 
effect of FLexp on respiratory muscle oxygen consumption (VO2RM) during maximal exercise, a 
sample of highly-trained male distance runners (n=18; O2 max = 74.28 ml·kg-1·min-1) 
completed an incremental exercise test to exhaustion on a treadmill. Based on flow-volume loop 
analysis, subjects were separated into two groups, flow-limited (FL) and non-flow limited 
(NFL). During a second visit, runners performed three separate trials of voluntary hyperpnea, 
matching exercise ventilation ( E) at 80%, 90%, and 100% of maximal exercise while standing 
on the treadmill.  Respiratory muscle O2 consumption (VO2RM) was estimated during each 
voluntary hyperpnea trial. A one-tailed, independent samples t-test detected a significantly 
greater VO2RM in FL compared to NFL (P = 0.043). E at O2 max was also greater in FL vs. 
NFL (P = 0.029). No differences were found between expiratory reserve volume (ERV), tidal 
volume (VT), or breathing frequency (fb) during maximal exercise. When co-varying for E at 
O2 max, there was no significant difference in VO2RM between groups, suggesting that the 
greater oxygen cost of breathing in flow-limited individuals is a consequence of the greater VE 
and not due to differences in breathing mechanics associated with flow limitation. 
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CHAPTER ONE 
INTRODUCTION 
  During the expiratory phase of the breathing cycle, there is a maximum flow rate that 
can be achieved. This upper limit to the generation of expiratory flow is caused by airway 
collapse as a result of extremely high pleural pressure. When flow is plotted versus volume 
during a forced expiratory maneuver, a boundary for maximal expiratory flow is established. 
Expiratory flow limitation (FLexp) occurs when the exercise tidal flow-volume loops (FVLs) 
impinge on the maximal flow-volume envelope. The flow-volume loop method of detecting 
FLexp describes the extent of flow-limitation as the percentage of tidal volume (VT) which 
corresponds to the encroachment of the FVLs on the maximal flow-volume envelope. FLexp has 
been defined as an impingement of the FVL on the maximal flow-volume envelope which 
corresponds to 50% of VT or more (Chapman, Emery, & Stager, 1998).  
FLexp occurs as a result of the achievement of maximum flow rates, and healthy 
individuals who display FLexp are described as having respiratory systems that are highly 
adapted to endurance exercise. During heavy to maximal exercise, highly-trained athletes are 
capable of displacing extremely large amounts of ambient gas, and therefore it is not uncommon 
for these individuals to reach FLexp. In fact, most highly-trained individuals demonstrate a 
substantial amount of FLexp during maximal exercise, and in some cases, up to 75% of VT is 
flow-limited (Johnson, Saupe, & Dempsey, 1992). Is there a price to pay for the attainment of 
FLexp in highly-trained endurance athletes?  Previous investigations on this population have 
shown that FLexp poses mechanical constraints to exercise ventilation ( E) (Johnson, et al., 
1992; Chapman, et al., 1998) and masks the expression of ventilatory drive (McClaran, Pegelow, 
Wetter, & Dempsey, 1999). However, the inability to increase E in flow-limited athletes 
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during maximal exercise does not apparently constrain pulmonary oxygen delivery (Johnson et 
al., 1992; Chapman et al., 1998).  
During maximal exercise in healthy, untrained individuals, 10% of O2 max is devoted 
to respiratory muscle oxygen consumption (VO2RM) (Aaron, Johnson, Seow, & Dempsey, 1992), 
and individuals who utilize a substantial portion of ventilatory reserve during maximal exercise 
commit 13 to 15% of O2 max to respiration (Aaron et al., 1992). Previous investigations have 
shown an exponential increase in VO2RM as E increases with exercise (Aaron et al., 1992; 
Johnson, et al., 1992; Coast et al, 1993). Although E at O2 max is not generally regarded as 
a cause of exercise limitation in healthy, untrained individuals, the superior level of E at O2 
max that is displayed in highly-trained endurance athletes likely requires a substantially greater 
VO2RM compared to healthy, untrained individuals. The oxygen cost of exercise hyperpnea in 
elite distance runners has been estimated as 11 to 16% of O2 max without discriminating 
between the flow-limited and non-flow limited runners. Nevertheless, the high level of E that 
is reached in highly-trained athletes during maximal exercise may be considered a potential 
cause of exercise limitation in that it causes a constraint, or rather, a competition for oxygen 
supplies between the ventilatory musculature and the metabolically active tissues.  It may be that 
the additional metabolic cost of the elevated E typical of FLexp imposes an even greater limit 
on the metabolic capability of the skeletal muscles while exercising at heavy to maximal exercise 
intensities.  
The highly-adapted pulmonary system characteristically demonstrates a superior level of 
E, and consequentially, FLexp results. This brings into question the potential advantages and 
disadvantages of the highly-adapted pulmonary system. In general, a greater E results in 
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greater oxygen delivery to and removal of carbon dioxide from the working muscles.  In this 
case, however, a “point of diminishing returns” may be reached such that the added cost of 
breathing caused by a greater E (or FLexp) offsets the expected additional oxygen delivery.   
Purpose of the Study 
To examine potential differences in E and VO2RM between flow-limited and non-flow 
limited, highly-trained distance runners during heavy to maximal exercise.  
Significance of the Study 
 During heavy to maximal exercise, the achievement of FLexp is common in highly-trained 
endurance athletes. The ability of these individuals to reach FLexp results from the maximal 
utilization of ventilatory reserve as a strategy to maximize E. However, the ability of the 
highly-adapted pulmonary system to reach extremely high levels of E may come with 
consequences. The increase in airway resistance that is characteristic of FLexp may elevate the 
oxygen cost of exercise hyperpnea. Previous investigation has shown that 13-15% of total body 
oxygen consumption during maximal exercise ( O2 max) is required by the respiratory muscles 
in individuals who utilize most of their ventilatory reserve, compared to 10% of O2 max in 
healthy individuals with less adapted respiratory systems. Furthermore, given that FLexp results 
from the maximal utilization of ventilatory reserve, it is unknown if E is greater in flow-
limited versus non-flow limited individuals who are highly-trained. The effect of FLexp on the 
oxygen cost of exercise hyperpnea provides a key step in the elucidation of limitations to 
exercise capacity in highly-trained endurance athletes. Shedding light on the relationship 
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between FLexp and VO2RM may open doors for further research on the mechanical constraints to 
E, the work of breathing, and exercise performance in highly-trained endurance athletes.      
Limitations 
The study was limited by the following: 
1. The method of detecting FLexp consisted of placing the average FVL within the maximal 
flow-volume loop. Correct placement of the average FVL requires inspiratory capacity 
(IC) maneuvers during exercise. Due to the lack of familiarity of inspiring to total lung 
capacity (TLC), it is conceivable that not all IC maneuvers were performed correctly 
during the O2 max test and mimic trials.  
2. Individuals who demonstrated FLexp of 5% or less were categorized as non-flow limited, 
and individuals who demonstrated FLexp of 35% or more were categorized as flow-
limited. The arbitrary establishment of the boundaries which define FLexp was set in 
order to ensure that the extent of FLexp was substantial enough to separate flow-limited 
and non-flow limited runners.  
3. The age range of subjects who participated in the present study was limited to 18 to 30 
years. Therefore, the conclusions that are drawn from the present study should not be 
interpreted to represent individuals outside of this age range. 
4. Only white males were recruited to participate in the present study. Therefore, the 
conclusions drawn from the study should not be interpreted to represent the female or 
non-white populations. 
V
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5. The highly-trained individuals who participated in the study were distance runners. The 
conclusions drawn from the present study may not represent highly-trained endurance 
athletes who are trained for other modes of exercise, such as cycling or swimming. 
Assumptions 
The basic assumptions of the study are as follows: 
1. Subjects fasted during the 6 hours preceding each experimental testing session. 
2. Resting O2 is the same between standing and voluntary hyperpnea.  
3. The difference in total body O2 between standing rest and the corresponding voluntary 
hyperpnea trials accounts for the work performed by only the muscles that were used for 
hyperpnea.  
4. The muscle groups which are required for E during voluntary hyperpnea were the same 
muscle groups used for E during the O2 max test. 
5. Matching breathing frequency (fb), VT, and EELV between exercise and voluntary 
hyperpnea is a valid method for mimicking the work of breathing (Coast et al., 1993).  
6. A statistically significant difference in VO2RM between flow-limited and non-flow 
limited runners is attributed a difference between groups in E, FLexp, or a combination 
of the two. 
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Hypotheses 
The present study was designed to test the following null hypotheses: 
1. FLexp does not vary enough to separate flow-limited and non-flow limited highly-trained 
distance runners into groups with 35% flow-limitation or more and 5% flow-limitation or 
less, respectively. 
The following null hypotheses were to be tested only if the first null hypothesis was rejected. 
2. There are no significant differences in age, height, mass, O2 max, or maximal heart rate 
(HR max) between flow-limited and non-flow limited subjects. 
3. Pulmonary function variables, which include forced vital capacity (FVC), forced 
expiratory volume in one second (FEV1), FEV1 as a percentage of FVC, forced 
expiratory flow from 25% to 75% of VT (FEF25-75), and peak expiratory flow rate 
(PEFR), are not significantly different between flow-limited and non-flow limited 
runners. 
4. E at maximal exercise is not significantly greater in the flow-limited group compared to 
the non-flow limited group during maximal exercise. 
5. O2RM is not significantly greater in the flow-limited group compared to the non-flow 
limited group during maximal exercise.  
6. When co-varying for E at O2 max, there is no significant difference in O2RM 
between flow-limited and non-flow limited subjects. 
7. During maximal exercise, expiratory reserve volume (ERV) is not significantly different 
between flow-limited and non-flow limited groups. 
V
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8. During submaximal exercise (80% and 90% of O2 max), there is no significant 
difference in E between flow-limited and non-flow limited subjects. 
9. During submaximal exercise (80% and 90% of O2 max), there is no significant 
difference in VO2RM between flow-limited and non-flow limited subjects. 
Definitions of Terms 
1. End-Expiratory Lung Volume (EELV). The volume of gas remaining in the lungs at the 
end of expiration, including residual volume (Johnson, Weisman, Zeballos, & Beck, 
1999). 
2. Exercise hyperpnea. The augmentation of ventilation from rest during exercise (Brooks, 
Fahey, & Baldwin, 2005, pp. 277-278). 
3. Expiratory Flow-Limitation (FLexp). The percentage of VT that meets or exceeds the 
expiratory boundary of the maximal flow-volume loop (Johnson et al., 1999). 
4. Expiratory Reserve Volume (ERV). The volume of gas remaining in the lungs at the end 
of expiration, excluding residual volume (Brooks et al., 2005, p. 263). 
5. Flow-Volume Loops (FVLs).  Lung volume plotted against inspiratory and expiratory 
flow (Johnson et al, 1999). 
6. Inspiratory Capacity (IC) Maneuver. A maximal inspiration during exercise that begins at 
EELV. This maneuver is used for a) the correction of drift due to slight differences in the 
measurement of inspiratory and expiratory flow rates and b) the placement of the tidal 
FVLs within the maximal flow-volume envelope (Johnson et al., 1999).  
7. Maximal Oxygen Consumption (VO2 max). The maximum rate that an individual can 
consume oxygen (Brooks et al., 2005, pp. 5-6).  
V
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8. Respiratory Muscle Oxygen Consumption (VO2RM). Total body O2 while mimicking 
exercise hyperpnea minus total body O2 at rest. This is considered to be the amount of 
oxygen consumed by the respiratory muscles for a given intensity of steady state exercise 
(Aaron, Johnson, Seow, Dempsey, 1992). 
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CHAPTER TWO 
REVIEW OF LITERATURE 
Expiratory Flow Limitation: Definition and Mechanics 
FLexp is defined as the percent of VT that meets or exceeds the expiratory boundary of the 
MFVL (Johnson, Weisman, Zeballos, & Beck, 1999). Respiratory disease patients are typically 
flow-limited due to either airway inflammation, airway constriction, or a combination of the two 
(Bousquet, Jeffery, Busse, Johnson, & Vignola, 2000). In healthy, untrained individuals who are 
free from chronic airflow limitations, FLexp typically is not present during rest to maximal 
exercise (Aaron, Seow, Johnson, & Dempsey, 1992). However, in most healthy individuals who 
are highly-trained for endurance competition, FLexp is present during exercise intensities above 
85% of O2 max (Johnson et al., 1992).  
The onset of FLexp in highly-trained endurance athletes during heavy to maximal exercise 
is due largely to the extreme amount of expiratory pressure that is generated. When thoracic 
pressure surrounding the airways exceeds the pressure that is inside the airways, the airways 
collapse (West, 2008). Due to this phenomenon, termed dynamic airway compression, expiratory 
flow becomes “effort independent,” which means that an increase in expiratory effort will not 
result in an increase in flow rate (West, 2008).  
Ventilatory Constraints in Respiratory Disease 
FLexp is common in individuals with respiratory disease. Understanding the similarities 
and differences in the physiological nature of FLexp between the diseased and highly-trained 
populations may provide insight into potential exercise limitations in highly-trained endurance 
athletes who are flow-limited. 
V
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Patients with chronic airflow limitation such as chronic obstructive pulmonary disease 
(COPD) commonly demonstrate FLexp during low to moderate exercise intensities (O’Donnell, 
Revill, & Webb, 2001). During incremental exercise to exhaustion, it is typical for these patients 
to terminate exercise before reaching maximal exercise capacity. The early termination of 
exercise is associated with a rating of perceived breathlessness, or dyspnea (O’Donnell et al., 
2001). The remarkable inability to generate flow during a maximal expiratory maneuver during 
rest in the diseased population greatly restricts the expansion of VT with an increase in exercise 
intensity. At low to moderate exercise intensities, therefore, strategies for expanding VT in 
COPD patients differ from those used by healthy individuals who are free from limitations to the 
generation of expiratory flow. In diseased patients, EELV increases in an attempt to escape the 
flow-limited portion of expiration, and EILV must also increase in order to expand VT (Diaz, et 
al., 2000; Johnson, Scanlon, & Beck, 1995). The increase in EELV above resting levels with 
exercise, termed dynamic hyperinflation (DH), is significantly correlated with the dyspnea rating 
in COPD patients during exercise (O'Donnell, Webb, and Lam, 1998). As a result, FLexp and its 
affect on dynamic lung volumes are limiting factors to exercise capacity in lung disease patients 
with chronic airflow limitation. 
Ventilatory Constraints in Highly-Trained Endurance Athletes 
There are key differences in resting pulmonary function between individuals with 
respiratory disease and highly-trained endurance athletes which allow highly-trained endurance 
athletes to generate far superior levels of expiratory flow. A major difference between the two 
populations is the extremely large amount of flow that highly-trained individuals are capable of 
generating during a maximal expiration. In a study by Johnson, Saupe, and Dempsey (1992) on a 
group of highly-trained male distance runners (n = 8; O2 max = 73 ± 1 ml·kg-1·min-1), group V
15 
 
mean peak expiratory flow rate (PEFR) reached as high as 12 L·s-1, group mean forced 
expiratory flow rate at 50% of VC (FEF50%) was 5.94 L·s-1, and group mean forced  expiratory 
volume in one second (FEV1) was 4.98 L ( O2 max = 73 ± 1 ml·kg-1·min-1; age = 25 ± 1 yrs). 
These values can be compared to predicted values of 10.39 L·s-1, 4.80 L·s-1, and 4.69 L·s-1 for 
PEFR, FEF50%, and FEV1, respectively (Hankinson, Odenkrantz, & Fedan, 1999). Pulmonary 
function measurements of 2.98 L·s-1, 0.43 L·s-1, and 0.94 L, for PEFR, FEF50%, and FEV1 
respectively, were measured in a group of COPD patients (age = 66 ± 8 yrs) (O’Donnell et al., 
2001). These pulmonary function values can be compared to 6.96 L·s-1, 3.55 L·s-1, and 2.85 L·s-1 
for PEFR, FEF50%, and FEV1 respectively in a group of age-matched, apparently healthy 
individuals (age = 63 ± 7) (O’Donnell et al., 2001). 
Relative to the healthy sedentary population, highly-trained endurance athletes are 
capable of generating considerably large flow rates during both inspiration and expiration at 
heavy to maximal exercise intensities, and in most cases, expiratory flow during maximal 
exercise is equivalent to a substantial portion of expiratory flow during a resting maximal 
expiratory maneuver. In some cases up to 75% of the tidal FVL meets or exceeds the expiratory 
portion of the maximal flow-volume envelope in highly-trained endurance athletes during 
maximal exercise (Johnson et al., 1992). In healthy, sedentary individuals, the extent of FLexp is 
much less than in highly-trained athletes. Aaron et al. (1992) measured the amount of FLexp in a 
group of healthy male individuals (n = 8, O2 max = 51.1 ± 2.6 ml·kg-1·min-1). Group mean 
FLexp was 36.3% of VT, but the three subjects who qualified as highly-trained reached a mean 
FLexp of 70% of VT (Aaron, et al., 1992), indicating a substantially greater constraint to E in 
highly-trained athletes compared to healthy sedentary individuals. 
V
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Not unlike the diseased population, once a substantial amount of FLexp has been reached 
in highly-trained individuals, there must be a strategy for increasing E as the exercise intensity 
increases. Potential tactics for increasing E include (1) increasing EELV, which moves the 
tidal FVL away from the flow-limiting portion of the MFVL, (2) increasing EILV, (3) increasing 
peak flow at the beginning of expiration, or any combination of the three. In the study by 
Johnson et al. (1992), six of the eight subjects increased EELV at a constant VT from heavy to 
maximal exercise, while the remaining two chose to increase peak flow at the beginning of 
expiration.  
The lung volume response to FLexp was also investigated in a study by McClaran, Wetter, 
Pegelow, and Dempsey (1999). In their study, a group of trained male cyclists (N = 6; VO2 max 
= 65 ± 8 ml·kg-1·min-1) performed four separate trials of incremental exercise to exhaustion on a 
cycle ergometer. With two of the trials, FLexp was reduced by breathing a low density gas 
mixture (HeO2). One HeO2 trial comprised of added dead space (which was used as a ventilatory 
stimulant), while the other did not. With the remaining two trials, FLexp was superficially 
increased using a high density gas mixture (N2O2), one trial with and one trial without added 
dead space. In all trials, adding dead space resulted in an increase in exercise E, which was 
partly explained by an increase in VT. During heavy to maximal exercise (equal to and above 
85% of VO2 max), adding dead space during the N2O2 trial resulted in a significantly greater 
EELV than when dead space was added during heavy to maximal exercise while breathing HeO2 
(P < 0.05), indicating that, when FLexp is present during heavy to maximal exercise, individuals 
ventilate at higher lung volumes (McClaran et al., 1999).  
V
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The elevated EELV during heavy to maximal exercise in flow-limited athletes may be 
associated with a greater oxygen cost of exercise hyperpnea due to greater elastic work 
performed by the inspiratory muscles. Collett & Engel (1986) investigated the effect of an 
elevated EELV on the oxygen cost of exercise hyperpnea in a group of apparently trained, 
healthy male subjects (N = 5). Two voluntary hyperpnea trials were carried out at a constant VT, 
fb, ratio of inspiratory to total breathing cycle duration, and transpulmonary pressure. One trial 
consisted of voluntary hyperpnea at an EELV at functional residual capacity (FRC), while the 
second trial consisted of voluntary hyperpnea with an EELV that was increased to 37% of 
inspiratory capacity. While ventilating at a high lung volume, VO2RM  was 41 ± 11 percent 
greater than when subjects ventilated with an EELV at FRC (P < 0.05). Furthermore, Collett & 
Engel (1986) found that when the work of breathing at a high lung volume was normalized for 
the decrease in maximal inspiratory pressure while ventilating with an EELV at FRC, VO2RM 
was not significantly different between trials (P > 0.70). Therefore, the difference in VO2RM 
between groups was attributed to the difference in EELV during voluntary hyperpnea. 
During maximal exercise, FLexp also results in a reduced ventilatory response. The 
previously mentioned study by McClaran et al. (1999) found that, during maximal exercise while 
breathing HeO2, the ventilatory response (Δ E/ΔPETCO2) to added dead space was 3.1 ± 1.8 
L·mm Hg-1 versus 1.1 ± 1.6 L·mm Hg-1 during the artificial induction of FLexp. Johnson et al. 
(1992) investigated the response to a ventilatory stimulus during heavy exercise in a group of 
competitive male distance runners. Subjects completed two separate, three-minute trials at 
maximal intensity, as well as two separate three-minute trials at a submaximal intensity (10mph 
at a 0% grade). Two trials comprised of an inspired fraction of O2 (FIO2) of 0.16 during both 
submaximal and maximal exercise, the third trial included an inspired fraction of CO2 (FICO2) of 
V
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0.04 during maximal exercise, and the fourth consisted of an FICO2 of 0.06 during submaximal 
exercise. The induced hypoxia trial resulted in a decrease in SaO2 from 93 ± 1% to 75 ± 2% 
during maximal exercise, but E did not change significantly (167 ± 5 L· min-1 while breathing 
normal air vs. 166 ± 7 L· min-1 in hypoxia). Likewise, hypercapnia increased PETCO2 from 38 ± 1 
mm Hg to 61 ± 2 mm Hg, but E did not change significantly (167 ± 5 L·min-1 vs. 168 ± 5 
L·min-1). During the submaximal exercise trials, all subjects significantly increased VE during 
both the hypercapnia and the hypoxia trials (hypercapnia, 120 ± 5 L·min-1; hypoxia, 99 ± 4 
L·min-1; normal air, 73 ± 1 L·min-1), indicating that the substantial extent of FLexp during 
maximal exercise (61 ± 7% of VT) results in a decreased ventilatory response. 
More evidence for a decrease in the ventilatory response to chemical stimuli in highly-
trained endurance athletes who are flow-limited during exercise is provided by Derchak et al. 
(2000), who investigated the relationship between the resting hypoxic ventilatory response 
(HVR) and arterial oxygen saturation (SaO2) during maximal exercise in a group of flow-limited 
distance runners compared to a group of non-flow limited distance runners (N = 16; VO2 max = 
75.8 ml·kg-1·min-1). A significant relationship between resting HVR and SaO2 at maximal 
exercise (r = 0.92, P < 0.05) was found in the athletes who were not flow-limited during 
maximal exercise (N = 8; VO2 max = 75.6 ± 4.8 ml·kg-1·min-1), and there was no relationship 
between the resting HVR and SaO2 during maximal exercise (r = 0.49, P > 0.05) in the flow-
limited athletes (N = 8; VO2 max = 75.9 ± 4.1 ml·kg-1·min-1). When FLexp was controlled for, 
the entire group of athletes displayed a significant relationship between resting HVR and SaO2 at 
maximal exercise (r = 0.69, P = 0.007), indicating that the ventilatory response to chemical 
stimuli is masked by FLexp. 
V
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In highly-trained endurance athletes, the alveolar to arterial O2 pressure difference 
increases 2.5 to 3-fold from rest to maximal exercise (Dempsey, 1986), which is partially 
compensated by the strong hyperventilatory response. What is the consequence of ventilatory 
constraints to gas exchange at the level of the lung in flow-limited athletes? Chapman et al. 
(1998) investigated the ability of highly-trained male distance runners who are flow-limited (N = 
5; VO2 max = 73.5 ± 5.7 ml·kg-1·min-1) not only to increase E during maximal exercise in 
hypoxia (FIO2 = 0.187), but also to maintain SaO2 between normoxia and hypoxia at maximal 
exercise compared to a group of non-flow limited individuals at the same fitness level (N = 5;   
O2 max = 68.1 ± 5.3 ml·kg-1·min-1). While the hypoxia trial resulted in a significant increase 
in E at maximal exercise in the group of non-flow limited athletes (140.9 ± 13.4 L·min-1 in 
normoxia vs. 154.7 ± 11.9 L·min-1 in hypoxia, P < 0.05), there was no significant difference in 
E at maximal exercise between normoxia and hypoxia in the flow-limited group of athletes 
(159.5 ± 9.4 L·min-1 in normoxia vs. 162.3 ± 6.0 L·min-1 in hypoxia). Although it is apparent that 
FLexp is a source of constraint to increasing E during maximal exercise, the magnitude of the 
decline in SaO2 from normoxia to hypoxia was not significantly different (P > 0.05) between 
flow-limited and non-flow limited athletes (Chapman, Emery, & Stager, 1998), indicating that 
there is no consequence to pulmonary oxygen delivery in flow-limited athletes during maximal 
exercise.  
Presently, the literature on highly-trained endurance athletes and FLexp seems to suggest 
that the work of exercise hyperpnea, and therefore, the oxygen cost of exercise hyperpnea is 
elevated as a consequence of FLexp during heavy to maximal exercise. Furthermore, it appears 
that the elevated oxygen cost of exercise hyperpnea may not only be due to the increase in 
EELV, but it may also be due to amount of expiratory pressure that is generated by the muscles 
V
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which aide in expiration against an elevated airway resistance. Johnson et al. (1992) measured 
transpulmonary pressure in their group of highly-trained distance runners, and showed that, 
while all of the runners reached the maximum level of pressure which contributes to expiratory 
flow, half of them generated a substantial amount of expiratory pressure beyond that which was 
necessary to reach FLexp. Therefore, there is likely a considerable amount of work that is 
performed during the expiratory portion of the breathing cycle that does not result in an increase 
in flow rate.  
The Oxygen Cost of Exercise Hyperpnea in Healthy Individuals 
The first study to measure VO2RM during different intensities of exercise by matching the 
ventilatory mechanics of exercise hyperpnea was the previously mentioned study by Aaron et al. 
(1992). In their group of eight healthy subjects, VO2RM comprised of 10 ± 0.7 percent of total 
body O2 max. Out of the eight healthy subjects, however, the three subjects who were 
considered highly-trained dedicated 13 to 15% of total body O2 to fueling the respiratory 
muscles during maximal exercise. The study by Aaron et al. (1992) also provided a regression 
equation describing the relationship between the work of breathing and VO2RM. This equation 
was used by Johnson et al. (1992) to estimate VO2RM in their group of highly-trained distance 
runners. In that study, it was estimated, based on the regression equation that was established by 
Aaron et al.(1992), that the oxygen cost of exercise hyperpnea during maximal exercise 
comprised of 13% of total body O2 (range 11 to 16%). 
The oxygen cost of exercise hyperpnea from a low to maximal exercise intensity depends 
mainly on exercise E. Martin & Stager (1981) measured VO2RM in a group of endurance 
trained (N = 8) and non-endurance trained (N = 8) females. In that study, VO2RM was measured 
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by maintaining a E of 30 L·min-1 for four minutes, and E was increased by 30 L·min-1 every 
four minutes thereafter until a given level of E could not be sustained for the full four-minute 
period. It was found that VO2RM was not significantly different between groups over the same 
range of E. Furthermore, the relationship between E and VO2RM in the study by Martin and 
Stager (1981) was nonlinear. As E increases from rest to maximal exercise, VO2RM increases 
exponentially. The nonlinear relationship between E and VO2RM has also been shown in a 
group of healthy males (Coast, et al., 1993), a group of physically active males (Anholm, 
Johnson, & Ramanathan, 1987), and in a group of highly-trained male distance runners (Johnson 
et al., 1992). With the extreme levels of E that have been measured in highly-trained endurance 
athletes while exercising at max, it is likely that small differences in exercise hyperpnea during 
maximal exercise will result in substantial differences in VO2RM. Therefore, it is likely that the 
superior level of E that is reached by highly-trained athletes results in a greater VO2RM. 
Conclusions 
Dynamic airway compression during maximal exercise leads to FLexp, resulting in an 
increase in airway resistance. Due to the extremely large amount of expiratory pressure that is 
generated during maximal exercise in highly-trained distance runners, FLexp commonly occurs in 
this population. While FLexp is also a common occurrence in lung disease patients, the onset of 
FLexp takes place at a much lower exercise intensity in individuals with obstructive lung disease 
due to differences in resting pulmonary function values between the two populations. The 
achievement of FLexp in highly-trained endurance athletes is a result of the ability to maximize 
the expiratory flow rate. 
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The mechanical constraints to E that are imposed by FLexp in highly-trained endurance 
athletes during heavy to maximal exercise do not appear to confine oxygen delivery at the level 
of the lung.  Strategies for increasing E during heavy to maximal exercise in flow-limited 
athletes include increasing dynamic lung volume in order to escape the flow-limited portion of 
VT, as well as increasing peak flow at the beginning of expiration. The decrease in lung 
compliance during inspiration, as well as the increase in expiratory flow against an elevated 
airway resistance may affect the oxygen cost of exercise hyperpnea.  
Healthy, untrained individuals, who typically do not ventilate enough to achieve FLexp, 
commit 10% of total body O2 to respiratory muscle work during maximal exercise. Highly-
trained endurance athletes, however, dedicate upwards of 16% of total body O2 to the 
respiratory muscles during maximal exercise. The substantially greater VO2RM in the highly-
trained population is likely due to the curvilinear relationship between E and VO2RM.  
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CHAPTER THREE 
METHODS 
Subjects 
 Eighteen highly-trained male distance runners were recruited to participate in the present 
study. The participants of the study were competitive in events ranging in distances from 800 
meters to the marathon. Subjects were recruited from the city of Bloomington, Indiana, and were 
members of high school, collegiate, and post-collegiate distance running programs, as well as 
local running clubs. Exclusion criteria comprised of the presence of bronchial asthma, a O2 
max of less than 65 ml·kg-1·min-1, and an age outside the range of 18 to 30. All participants gave 
written informed consent and completed a modified physical readiness questionnaire prior to 
participating in the study. Each subject was free of cardiopulmonary disease. All testing 
procedures and informed consent was approved by the Indiana University Human Subjects 
Institutional Review Board. 
Study Design 
 Subjects were instructed to fast during the six hours prior to each laboratory visit. 
Experimental testing included two separate visits to the Indiana University Human Performance 
Laboratory. With the first session, subjects performed a O2 max test on the treadmill. During 
the second session, subjects voluntarily matched exercise hyperpnea.  
 Session I. Upon arrival to the laboratory, each subject gave written informed consent and 
completed a modified physical readiness questionnaire. Body mass and height were then 
recorded. A warm-up consisting of light jogging was completed prior to testing. The speed, 
duration, workload, and location of the warm-up were left to the discretion of each individual. 
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Warm-ups lasted no longer than 15 minutes in duration. Subjects then performed three to six 
maximal flow-volume maneuvers. 
 After the collection of pre-exercise MFVLs, subjects were equipped with heart rate 
monitors (Polar, Inc.) before beginning the O2 max test. Physiological variables were collected 
throughout, and recorded at the end of each minute for five minutes of standing rest and for each 
minute of the O2 max test.  
 Within the five minutes following the O2 max test, each subject removed his heart rate 
monitor and was allowed a period of recovery while investigators prepared the data acquisition 
program for the collection of MFVLs. Subjects then performed an additional three to six 
maximal flow-volume maneuvers. Each subject was encouraged to perform the maximal flow-
volume maneuvers as soon as possible following the O2 max test in order to include the effect 
of exercise-induced bronchodilation.  
Session II. Upon arrival to the laboratory for the voluntary hyperpnea trials, body mass 
was recorded for each subject. Subjects then performed three to six maximal flow-volume 
maneuvers. Subjects were equipped with a heart rate monitor and physiological variables were 
measured throughout, and recorded at the end of each minute for five minutes of standing rest.   
 After five minutes of standing rest, subjects mimicked three separate levels of exercise 
hyperpnea while standing for four minutes, each level of E corresponding to 80, 90, and 100 
percent of maximal exercise. The voluntary hyperpnea trials were separated by at least five 
minutes to ensure recovery of the respiratory muscles between trials. The trials were completed 
in random order. Prior to the first voluntary hyperpnea trial, subjects were allowed at least one 
minute of familiarization. The extent of familiarization depended how quickly the subject 
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learned to match ventilatory mechanics. Some individuals required more time for familiarization 
than others.  
 During the five minutes following the final voluntary hyperpnea trial, each subject 
removed his heart rate monitor and was allowed a period of recovery while investigators 
prepared the data acquisition program for the collection of MFVLs. Subjects then performed 
three to six maximal maneuvers. Each subject was encouraged to perform the maximal 
maneuvers as soon as possible following the voluntary hyperpnea trials in order to include the 
effect of bronchodilation. All of the MFVLs were collected within five minutes following the 
last voluntary hyperpnea trial.   
Measurements 
Pulmonary Function. The pulmonary function variables were collected and recorded 
from the computer integration of the inspired and expired flow signals which were provided by a 
set of pneumotachographs (Series 3800, Hans Rudolph, Kansas City, MO). Pulmonary function 
measurements included vital capacity (VC), forced expiratory volume in one second (FEV1), 
forced expiratory flow from 75 to 25 percent of VC (FEF25-75), and peak-expiratory flow rate 
(PEFR). These measurements were used 1) as a method of screening to ensure that the subjects 
were free of pulmonary disease and 2) to detect inherent differences between experimental 
groups. 
VC represents the expired volume (in BTPS), during a forced expiration, from TLC to 
residual volume (RV). A total of six to twelve measurements of VC were collected during each 
visit to the laboratory. Of these, the largest expiratory volume was chosen to represent VC.  
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FEV1 and FEF25-75 were also measured throughout a series forced expirations. FEV1 is 
the expired volume beginning at TLC and ending after one second. FEF25-75 is the flow rate 
across the range of 75 to 25% of VC.  
Maximal Flow-Volume Loops (MFVL). A set of maximum effort ventilatory maneuvers 
was performed by each subject. Subjects began the maneuvers at RV, performed an inspiration to 
TLC, and then expired back to RV, each at maximum effort. A graph of flow vs. volume was 
plotted as a result of these maneuvers.  
The MFVL represents the maximal generation of flow that can be generated throughout 
the duty cycle. The expiratory portion of an MFVL is characterized by a sharp incline in flow, 
followed by a steady decline as the subject approaches residual volume. As exercise intensity 
increases, the tidal flow-volume loops approach the MFVL as individuals maximize the 
generation of flow. The MFVL serves as a boundary through which the exercise tidal flow-
volume loops cannot penetrate. As specified below, tidal flow-volume loops are plotted within 
the MFVL for the determination of expiratory flow limitation (FLexp).  
Maximal Oxygen Consumption (VO2 Max). O2 max was measured during an 
incremental exercise test to exhaustion on a motorized treadmill (Quinton, Bothell, WA). The 
treadmill speed remained constant throughout the test. The percent grade was set at zero during 
the first two minutes of exercise, and increased by two percent every two minutes until volitional 
exhaustion. The highest recorded O2 was accepted as O2 max if two of the following three 
criteria were met: 1) A heart rate of equal to or more than 90% of predicted heart rate max, 2) an 
RER of 1.10 or higher, and 3) an increase in absolute O2 of .15 L/min or less.  
Physiological variables were measured using a computer interfaced (DASYlab), indirect 
calorimetry system. Physiological measurements included E, absolute and relative O2, 
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carbon dioxide production ( CO2), and the respiratory exchange ratio (RER). E was 
measured by the computer integration of the inspired flow signal which was measured using a 
pneumotachograph. Dry expired gas was sampled at a rate of 300 ml·min-1 from a 5-Liter mixing 
chamber, and fractional concentrations of O2 and CO2 were determined by O2 and CO2 analyzers 
(AEI Technologies, Pittsburgh, PA). The O2 and CO2 analyzers were calibrated using 
commercially available gas mixtures within the physiological range. The fractional contents of 
the gas mixtures were verified by mass spectroscopy. Absolute O2 was calculated using the 
equation provided by the Haldane Transformation. Relative O2 was calculated by dividing 
absolute O2 by body mass in kilograms. CO2 was calculated by subtracting the inspired 
volume of CO2 from the expired volume of CO2. RER was calculated by dividing CO2 by 
absolute O2. Each subject wore a heart rate monitor (Polar, Inc.) during O2 max testing. 
Heart rate (beats·min-1) was sampled throughout, and recorded at the end of each minute.  
Voluntary Hyperpnea Trials. The matching of exercise hyperpnea for the calculation of 
VO2RM required subjects to match the mechanics of E. The validity of the methods by which 
exercise hyperpnea was matched has been established (Coast, et al., 1993). 
Isocapnia was maintained by inspiring from a Douglas bag filled with 5% CO2, 21% O2, 
and balance N2. In addition to the elevated CO2, a humidifier was added to the inspired side to 
moisten the inspired air for preventing throat discomfort throughout the voluntary hyperpnea 
trials. Each subject mimicked three separate levels of exercise hyperpnea, each corresponding to 
the relative exercise intensities of 80, 90, and 100 percent of O2 max. VT was matched using a 
real-time graph of volume changes with time on a computer monitor and fb was matched using a 
metronome. Careful attention was made to ensure that mean ERV (as a percent of VC), percent 
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flow limitation, and E did not differ between exercise and voluntary hyperpnea by more than 
five percent. Either the third or fourth minute of voluntary hyperpnea was selected for flow-
volume loop analysis, depending on which minute more closely matched the mechanics of 
exercise hyperpnea.  
Tidal FVL Analysis. Inspiratory and expiratory flow was measured using a set of 
pneumotachographs. Inspired and expired volume was calculated by computer integration of the 
flow signal. Data for each minute was saved in a separate file for subsequent analysis. Tidal 
FVLs were constructed using a computer program that selects flow and volume at the beginning 
and end of each breathing cycle and calculates the average FVL from 30 seconds of data 
collection. The data for the average tidal FVL representing the last half of the minute of interest 
(80%, 90%, and 100% of O2 max, and the third or fourth minute of voluntary hyperpnea) was 
plotted within the corresponding MFVL.   
FLexp was defined as the percent of VT that coincided with an impingement of the tidal 
FVL with the expiratory portion of the MFVL. Individuals with a VT that was at least 35% flow 
limited were classified as flow-limited subjects (FL). Those who demonstrated 5% or less flow 
limitation were grouped into the non-flow limited category (NFL). Although the criteria for 
inclusion into groups based on the degree of FLexp is arbitrary, the purpose of this method is to 
ensure that the effect of FLexp, as the independent variable, is clearly present. Individuals who 
were between 5 and 35 percent flow-limited were omitted from group analysis and used only for 
correlation analysis. 
Estimation of VO2RM. Total body O2 was measured during both standing rest and each 
voluntary hyperpnea trial. VO2RM was calculated by subtracting total body O2 during standing 
rest from total body O2 during the third or fourth minute of the voluntary hyperpnea trials. 
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This calculation is based on the assumption that the only difference between standing rest and 
mimicking exercise hyperpnea while standing is the work performed by the muscles which aid in 
pulmonary ventilation.   
Statistical Analysis of the Data 
 Differences in VO2RM and in E during maximal exercise between FL and NFL were 
analyzed using a one-tailed, independent samples t-test. Differences in all remaining maximal 
and submaximal variables were analyzed using a two-tailed, independent samples t-test. The 
alpha level for all statistical analyses was set at P < 0.05. The statistical software that was used 
for analyzing the data was the Statistical Package for the Social Sciences (IBM, Chicago).  
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
Subject Characteristics and Pulmonary Function 
There were no significant differences (P > 0.05) in age, height, weight, and O2 max 
between FL and NFL (Table 4.1). There was no significant difference (P > 0.05) in FEV1 
between groups (FL, 4.55 ± 0.66; NFL, 5.08 ± 0.52) (Table 4.2). However, FEV1/FVC was 
significantly greater in NFL compared to FL (89 ± 7.6 vs. 81 ± 6.1, P = 0.032). FEF25-75 was also 
significantly greater in NFL compared to FL (7.06 ± 1.01 vs. 5.13 ± 0.50 L·s-1, P < 0.001). No 
significant differences (P > 0.05) were detected in VC (FL, 5.68 ± 0.82 L; NFL, 5.74 ± 0.38 L) 
or in PEFR (FL, 10.47 ± 2.25 L·s-1; NFL, 10.75 ± 1.62 L·s-1) between groups. 
Resting pulmonary function values were compared to predicted resting pulmonary 
function values (Hankinson, Odencrantz, & Fedan, 1999) and are also presented in Table 4.2. 
None of the resting pulmonary function variables for FL were significantly different from 
predicted values (P > 0.05) (VC = 101 ± 15.2% of predicted; FEV1 = 97 ± 15.2% of predicted; 
FEV1/FVC = 97 ± 7.1% of predicted; FEF25-75 = 105 ± 12.0% of predicted; PEFR = 103 ± 21.0% 
of predicted).  All pulmonary function variables for NFL were in the normal range of predicted 
values (P > 0.05) except for FEF25-75 (VC = 103 ± 0.5% of predicted; FEV1 = 110 ± 14% of 
predicted; FEV1/FVC = 107 ± 9.1% of predicted; FEF25-75 = 147 ± 26.8% of predicted, P < 
0.001; PEFR = 107 ± 18.6% of predicted). 
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The Oxygen Cost of Exercise Hyperpnea and Ventilatory Mechanics During Maximal 
Exercise 
 The oxygen cost of exercise hyperpnea and ventilatory mechanics data during maximal 
exercise are presented in Table 4.3. The degree of FLexp during maximal exercise in FL was 55 ± 
11.3% of VT, and the extent of FLexp during maximal exercise in NFL was 0 ± 1.3% of VT. 
VO2RM was significantly greater in the flow-limited subjects compared to the non-flow limited 
subjects when the values are expressed both as a percent of O2 max and in milliliters per 
kilogram per minute (19.19 ± 8.44% vs. 13.25 ± 4.89% of O2 max, P = 0.043; 14.58 ± 6.66 vs. 
9.70 ± 3.64 ml·kg-1·min-1, P = 0.036). E at O2 max was also greater in FL compared to NFL 
(176.47 ± 23.29 L·min-1 vs. 157.54 ± 15.31 L·min-1, P = 0.029). After co-varying for E at  
O2 max, there was no significant difference in VO2RM (% of O2 max) between groups (P = 
0.101).  
 The ventilatory equivalent for oxygen consumption during maximal exercise was not 
significantly different between groups (P > 0.05) (FL, 34.58 ± 3.01; NFL, 32.67 ± 2.62). 
Likewise, the ventilatory equivalent for carbon dioxide output during maximal exercise was not 
significantly different between groups (P > 0.05) (FL, 30.52 ± 2.70; NFL, 28.63 ± 1.63).  
There were no significant differences (P > 0.05) in fb (FL, 58.50 ± 7.19 br·min-1;NFL, 
53.56 ± 7.28 br·min-1) or in VT (FL, 3.04 ± 0.41 L·br-1; NFL, 2.96 ± 0.25 L·br-1) during maximal 
exercise between flow-limited and non-flow limited subjects. In addition, no significant 
difference (P > 0.05) was detected in ERV during maximal exercise between groups (FL, 36 ± 
5.7% of VC; NFL, 35 ± 6.7% of VC).  
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The Oxygen Cost of Exercise Hyperpnea and Ventilatory Mechanics During 
Submaximal Exercise 
At 80% O2 max, there were no significant differences (P > 0.05) in VO2RM between FL 
and NFL when VO2RM is expressed both as a percentage of total body O2 and in milliliters per 
kilogram per minute (Table 4.5). At the same exercise intensity, E was greater in FL compared 
to NFL (113.67 ± 18.20 vs. 92.84 ± 10.14 L·min-1, P = 0.049). The ventilatory equivalent for 
carbon dioxide output at 80% O2 max was also greater in flow-limited versus non-flow limited 
subjects (29.35 ± 1.97 vs. 25.28 ± 1.81, P = 0.006). At 80% O2 max, the ventilatory equivalent 
for oxygen consumption, ERV, VT, and fb were not significantly different between groups (P > 
0.05). 
At 90% O2 max, there were no significant differences (P > 0.05) in VO2RM between FL 
and NFL when VO2RM is expressed both as a percent of total body O2 and in milliliters per 
kilogram per minute. E at 90% O2 max was greater in FL compared to NFL (142.15 ± 19.19 
vs. 113.51 ± 12.40 L·min-1, P = 0.019). The ventilatory equivalent for carbon dioxide output at 
90% O2 max was also greater in flow-limited versus non-flow limited subjects (29.88 ± 1.97 
vs. 25.35 ± 2.27, P = 0.006). In addition, there were no significant differences (P > 0.05) in the 
ventilatory equivalent for oxygen consumption, ERV, VT, or fb between groups during exercise 
at 90% O2 max. 
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Discussion 
The Oxygen Cost of Exercise Hyperpnea During Maximal Exercise 
The present study has shown that both VO2RM and E during maximal exercise are 
significantly greater in highly-trained distance runners who are flow-limited compared to those 
who are not flow-limited, rejecting the first two null hypotheses. These findings are consistent 
with previous research on highly-trained endurance athletes. Aaron et al. (1992) found a 3 to 5% 
greater oxygen cost of exercise hyperpnea in a group of flow-limited individuals compared to a 
group of non-flow limited individuals during maximal exercise.  
As previously mentioned, it has been established that VO2RM increases exponentially 
with an increase in E (Anholm et al., 1987; Coast et al., 1993; Johnson et al., 1992; Martin & 
Stager, 1981). When co-varying for E at O2 max, no statistical difference in VO2RM between 
groups was observed (P = 0.102). At maximal exercise, highly-trained endurance athletes 
operate at extremely high levels of E, and therefore a substantial proportion of total body O2 
is devoted to the respiratory muscles. The pulmonary systems of the endurance athletes who 
participated in the present study are well adapted to high-level endurance training, which results 
in the maximal utilization of ventilatory reserve, and consequentially, FLexp ensues (Aaron et al., 
1992; Johnson et al., 1992). Is the greater VO2RM, as a result of the achievement of mechanical 
constraints to the generation of expiratory flow due to the superior level of E at O2 max, or 
is it a result of the increase in airway resistance that is typical of FLexp? The results of the present 
study suggest that the difference in VO2RM between groups is explained by the superior level of 
E at O2 max that is achieved by flow-limited runners.   
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Comparisons of the ventilatory equivalents for oxygen consumption and carbon dioxide 
output during maximal exercise between flow-limited and non-flow limited endurance-trained 
athletes are consistent with previous studies (Chapman, et al., 1998; Derchak, Stager, Tanner, & 
Chapman, 2000). Previous work on flow-limited and non-flow limited athletes has shown that 
there are no significant differences in E/ O2 and in E/ CO2 between flow-limited and non-
flow limited athletes during maximal exercise (Chapman, et al., 1998; Derchak, et al., 2000). 
Furthermore, Derchak et al. showed that a significant relationship existed between resting HVR 
and SaO2 at O2 max in non-flow limited endurance-trained subjects, but there was no 
relationship between the two in flow-limited endurance-trained subjects during maximal 
exercise. These results suggest that the expression of ventilatory responsiveness to chemical 
stimuli is masked by FLexp. 
In the present study, the ventilatory equivalent for carbon dioxide output was 
significantly greater in the flow-limited group compared to the non-flow limited group during 
exercise at 80% O2 max, as well as 90% O2 max. Without measuring the ventilatory 
response to chemical stimuli, it is difficult to draw conclusions from these results. Perhaps the 
significant difference in E combined with the ventilatory equivalent for carbon dioxide output 
between groups during submaximal exercise, when there are less mechanical constraints to E, 
suggests a greater ventilatory drive in flow-limited versus non-flow limited runners, which may 
partially explain the achievement of FLexp in some highly-trained runners. However, further 
research is needed to support this conclusion.  
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Dynamic Lung Volumes in Expiratory Flow Limitation 
A link between FLexp and VO2RM may be the increase in EELV at heavy to maximal 
exercise, which is a strategy that is commonly employed for increasing the expiratory flow rate 
(McClaran, et al., 1999), and ultimately E in flow-limited individuals. While increasing E 
from heavy to maximal exercise is essential for removing carbon dioxide from the body and for 
increasing systemic oxygen delivery, it is unknown if a point is reached where the increase in 
oxygen delivery is offset by the oxygen cost of exercise hyperpnea. Perhaps VO2RM between 
groups was not explained solely by FLexp in the present study because ERV was not different 
between groups (Collett & Engel, 1986). In healthy untrained subjects, the strategy for increasing 
VT with exercise to max is to decrease EELV while holding EILV constant (Henke, Sharratt, 
Pegelow, & Dempsey, 1988). However, McClaran et al. (1999) showed that when the degree of 
FLexp was increased using N2O2 in a group of six competitive male cyclists, EELV was 
significantly elevated. Furthermore, in six of the eight highly-trained male distance runners who 
participated in the study by Johnson et al. (1992), EELV returned to the equivalence of, or even 
slightly above resting values during maximal exercise. In the remaining two subjects, however, 
flow rates were increased by generating high pressures very early during expiration. Although 
most of the subjects chose to increase EELV back to resting values or higher during maximal 
exercise, the mean EELV at maximal exercise remained below mean resting EELV. Therefore, it 
appears that the strategy that is employed for increasing flow rates during heavy to maximal 
exercise in flow-limited athletes is highly individualized. In the present study, VO2RM between 
groups appeared to be approaching significance (P = 0.102). Perhaps the majority of the flow-
limited subjects who participated in the present study “chose” to increase expiratory flow by 
generating high pressures very early in the expiratory phase rather than “choosing” to increase 
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EELV, explaining the failure to detect a significant difference in VO2RM during maximal 
exercise between groups when co-varying E. From an exercise performance standpoint, it is 
unknown which strategy for increasing expiratory flow is preferred.  
The Oxygen Cost of Exercise Hyperpnea During Submaximal Exercise 
During submaximal exercise (80% and 90% O2 max), VO2RM was not statistically 
different between groups. However, E was significantly greater in FL compared to NFL during 
exercise at both 80% and 90% O2 max. If E is significantly different between groups, it is 
expected based on previous research, that VO2RM would be significantly different as well. Why 
did this not occur in the present study? One explanation may lie in the unfortunately low number 
of subjects included in the submaximal exercise portion of the present study due to complications 
with matching ventilatory mechanics between exercise and voluntary hyperpnea at submaximal 
exercise intensities. Only six flow-limited, and five non-flow limited subjects were included in 
the submaximal exercise portion of the present study. From a statistical standpoint, the inherent 
variation between subjects that comes with measuring VO2RM may necessitate a greater sample 
size in order to show significance at an alpha level of 0.05 and a statistical power of 0.80.  
Another potential explanation for the failure to detect a significant difference in VO2RM 
in spite of a difference in E at both 80% and 90% O2 max may be the low level of E within 
each group. Perhaps the established slope of the relationship between E and VO2RM is not 
steep enough at this level of E to account for a difference in VO2RM. In the present study, at 
80% O2 max, flow-limited subjects had a mean E of 113.67 L·min-1 and a mean VO2RM of 
7.35 ml·kg-1·min-1. At the same exercise intensity, non-flow limited subjects had a mean E of 
92.84 L·min-1 and a mean VO2RM of 3.11 ml·kg-1·min-1. Based on the values of  E at 80% 
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O2 max in the present study, the data presented in the study by Martin and Stager (1981) predicts 
a VO2RM in our group of flow-limited athletes of 9.6 ml·kg-1·min-1, and a VO2RM in our group of 
non-flow limited athletes of 7.6 ml·kg-1·min-1. Furthermore, Johnson et al. (1992) estimated 
VO2RM over a range of E from resting to O2 max, based on previously published 
transpulmonary pressure measurements (Aaron, et al., 1992) in their group of elite distance 
runners. Using the mean values of E at 80% O2 max in the present study, the data provided 
by Johnson et al. estimates a VO2RM in our flow-limited subjects of 4.7 ml·kg-1·min-1, and a 
VO2RM in our non-flow limited subjects of 3.4 ml·kg-1·min-1. Based on the data provided by 
Martin and Stager (1981), as well as Johnson et al. (1992), it is highly unlikely that their 
estimates of VO2RM would yield a significant difference in VO2RM between groups at the level of 
E that was observed at 80% O2 max in our group of highly-trained athletes, given the 
standard deviation in the present data. 
 In the present study, at 90% O2 max, flow-limited subjects demonstrated a mean E of 
142.15 L·min-1 and a mean VO2RM of 7.39 ml·kg-1·min-1. At the same exercise intensity, non-
flow limited subjects demonstrated a mean E of 113.51 L·min-1 and a mean VO2RM of 4.52 
ml·kg-1·min-1. Based on the values of E at 90% O2 max in the present study, the data 
presented in the study by Johnson et al. (1992) predicts a VO2RM in the present group of flow-
limited subjects of 7.4 ml·kg-1·min-1, and a VO2RM in the present group of non-flow limited 
subjects of 4.8 ml·kg-1min-1. With the standard deviations that were observed in the measurement 
of VO2RM in our group of athletes, it is also unlikely that the relationship that was established 
between E and VO2RM in the study by Johnson et al. (1992) would predict a significant 
difference in VO2RM between FL and NFL in the present study. Therefore, although submaximal 
E was significantly greater in FL compared to NFL in the present study, previous studies seem 
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to agree with our results, which show that VO2RM is not significantly greater in flow-limited 
endurance athletes compared to non-flow limited endurance athletes during submaximal 
exercise. At 80% and 90% O2 max, the slope of the regression line describing the relationship 
between E and VO2RM may not be steep enough to explain a difference in VO2RM between the 
two experimental groups. 
 Pulmonary Function and Expiratory Flow Limitation  
 In determining the underlying causes of the presence of FLexp in highly-trained 
endurance athletes, the data from the present study suggest that submaximal and maximal E 
may not be the only contributors to the occurrence of FLexp during maximal exercise. In the 
present cohort of highly-trained distance runners, FEV1/FVC was significantly greater in NFL 
compared to FL (89 vs. 81%). Furthermore, FEF25-75 was also significantly greater in NFL (7.06 
vs. 5.13 L·s-1). These data suggest that, in non-flow limited individuals, there is more room 
available for the generation of flow across the mid-range of the expiratory portion of the MFVL. 
By definition, the classification of subjects into the flow-limited category depends highly on the 
ability to generate maximal expiratory flow. Therefore, the findings of the present study suggest 
that FLexp during maximal exercise may be partly due to a greater limitation to flow across the 
mid-range of a maximal expiratory maneuver.  
 In the present group of non-flow limited runners, the measured values of FEF25-75 were 
significantly greater than the predicted values. Contrary to our findings, Chapman et al. (1998) 
found that all pulmonary test values (FVC, FEV1, and MEF50) were within the normal range of 
predicted values in non-flow limited, highly-trained distance runners. Further contradicting the 
results of the present study, Chapman et al. (1998) found no significant differences in any of the 
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pulmonary test values between flow-limited and non-flow limited athletes. Further research 
focusing on pulmonary function variables in flow-limited and non-flow limited endurance 
athletes is necessary to reconcile the inconsistencies of the present study with previous findings. 
Implications for Performance 
What is the price to pay for an elevated oxygen cost of exercise hyperpnea during 
maximal exercise in highly trained endurance athletes? The extremely high levels of respiratory 
muscle work in highly-trained endurance athletes during maximal exercise require approximately 
14% to 16% of total cardiac output (Harms et al., 1998). Due to the substantial amount of blood 
flow that is required by the respiratory muscles during maximal exercise, competition for blood 
flow between the working respiratory muscles and the working locomotor muscles may be 
problematic for exercise performance. 
There is evidence that the diaphragmatic muscle fatigue, which normally occurs in 
highly-trained distance runners at exercise intensities as low as 85% O2 max (Johnson, 
Babcock, Suman, & Dempsey, 1993), is related to a decrease in exercise performance. There 
appears to be a sympathetically-mediated reflex in response to diaphragmatic fatigue which 
causes a decrease in blood flow to the locomotor muscles during exercise. St. Croix, Morgan, 
Wetter, & Dempsey (2000), found an increase in muscle sympathetic nerve activation as a result 
of fatiguing the diaphragm during voluntary hyperpnea in a group of seven healthy subjects 
(Males, N = 3; Females, N = 4). Harms et al. (1997) found a decrease in leg blood flow when the 
work of exercise hyperpnea was increased during maximal exercise in a group of trained male 
cyclists (N = 7; VO2 max = 64.3 ± 5.6 ml·kg-1·min-1) along with an increase in norepinephrine 
spillover, indicating that the decrease in leg blood flow may be due to muscle sympathetic nerve 
activity (Savard, et al., 1989). In a separate study, Harms, Wetter, St. Croix, Pegelow, and 
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Dempsey (2000) showed a significant decrease in time to exhaustion at a work rate of 90% O2 
max when the respiratory muscle load was increased in a group of trained male cyclists (N = 7; 
VO2 max = 63 ± 5 ml·kg-1·min-1). The differences in time to exhaustion between control and 
respiratory muscle loading and unloading was significantly correlated with the differences in 
both leg rating of perceived exertion and the dyspnea rating between control and respiratory 
muscle loading and unloading trials (Harms et al., 2000). The decrease in exercise performance 
during the respiratory loading trials was attributed to the decrease in locomotor muscle blood 
flow as a result of the increase in respiratory muscle work.  
While the work of breathing was not directly measured in the present study, the increase 
in the oxygen cost of exercise hyperpnea is presumably a result of the increased work of exercise 
hyperpnea, which occurred due to the elevated level of E at O2 max in the group of flow-
limited athletes who participated in the present study. Based on evidence of diaphragmatic 
fatigue in highly-trained distance runners while exercising at intensities as low as 85% O2 max 
(Johnson et al., 1993), it is likely that diaphragm fatigue was present in the current group of 
highly-trained endurance athletes during maximal exercise. Perhaps the greater amount of work 
performed by the respiratory muscles in the present group of flow-limited athletes led to 
vasoconstriction of the leg vasculature. It is unknown whether a sympathetically-mediated reflex 
activation exists to a greater extent in flow-limited compared to non-flow limited athletes while 
exercising at heavy to maximal intensities. Future research is required to shed light on this 
question.  
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CHAPTER FIVE 
SUMMARY, FINDINGS, IMPLEMENTATIONS, AND RECOMMENDATIONS 
Summary 
The main aim of the present study was to determine the effect of FLexp on the oxygen 
cost of exercise hyperpnea during heavy to maximal exercise in a group of highly-trained 
distance runners.  
The 18 subjects who participated in the study were highly-trained male distance runners 
between the ages of 18 and 30 and were recruited from local high school, collegiate, and post-
collegiate distance running groups. During the first visit to the Indiana University Human 
Performance Laboratory, subjects completed a series of pulmonary function tests along with a 
VO2 max test. During incremental exercise to max, pulmonary mechanics included VT, fb, ERV 
and percent flow limitation. During a second visit to the laboratory, subjects voluntarily matched 
the mechanics of exercise hyperpnea during three four-minute trials, each trial consisting of one 
of three levels of exercise hyperpnea. The levels of exercise hyperpnea that were voluntarily 
matched corresponded to 80%, 90% and 100% O2 max. VO2RM was the outcome variable of 
the voluntary hyperpnea trials. Subjects who demonstrated no less than 35 percent of flow 
limitation during maximal exercise (n = 9) were categorized as flow-limited. Subjects who 
demonstrated 5 percent or less of flow limitation during maximal exercise (n = 9) were 
categorized as non-flow limited. 
Statistical analysis of the data comprised of a one-tailed independent samples t-test for 
the detection of differences in VO2RM and E during maximal exercise between FL and NFL, 
with an alpha level of 0.05. Differences between groups for all other maximal and submaximal 
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exercise variables, as well as for pulmonary function variables, were analyzed using two-tailed 
independent samples t-tests with the alpha level set at 0.05.   
The analysis of the data revealed the following significant findings: 
1. VO2RM was significantly greater in FL compared to NFL during maximal exercise. 
2. E at O2 max was significantly greater in FL compared to NFL. 
3. When co-varying for E at O2 max, there was no significant difference in VO2RM 
during maximal exercise between FL and NFL. 
4. ERV during maximal exercise was not significantly different between FL and NFL. 
5. During submaximal exercise (80 and 90% O2 max), E was significantly greater 
in FL compared to NFL. 
6. During submaximal exercise (80 and 90% O2 max), E/ CO2 was significantly 
greater in FL compared to NFL. 
Conclusions 
1. Highly-trained distance runners who demonstrate a substantial amount of flow 
limitation during maximal exercise commit a greater proportion of total body O2 to 
fuel the respiratory muscles than individuals of the same aerobic fitness who are not 
flow-limited. 
2. Highly-trained distance runners who are flow-limited during maximal exercise 
demonstrate a greater level of exercise hyperpnea compared to highly-trained distance 
runners who are not flow-limited during maximal exercise. 
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3. The greater oxygen cost of exercise hyperpnea in highly-trained distance runners who 
are flow-limited compared to those who are not flow-limited during maximal exercise 
is attributed to the greater E at O2 max in flow-limited runners. 
4. The highly-trained distance runners who are flow-limited during maximal exercise 
demonstrate a greater drive to ventilate during submaximal exercise than highly-
trained distance runners who do not achieve a substantial amount of flow limitation 
during maximal exercise.  
Practical Implications 
The findings of the present study may be implemented into endurance training and 
research in the following ways: 
1. FLexp should be considered when training at altitude. Previous studies show that flow-
limited athletes are unable to increase E during maximal exercise. Based on the 
findings of the present study, flow-limited athletes would be at an advantage when 
exercising at or near maximal intensity due to their inability to increase E during 
maximal exercise in a hypoxic environment. Therefore, it is likely that while 
exercising at altitude, the oxygen cost of exercise hyperpnea would not be elevated.  
2. FLexp, by itself, should no longer be considered a source of an elevated oxygen cost 
of exercise hyperpnea in highly-trained endurance athletes. Rather, the source of the 
elevated oxygen cost of exercise hyperpnea in flow-limited athletes is the greater E 
during maximal exercise. Therefore, training strategies for decreasing FLexp during 
heavy to maximal exercise will not decrease the oxygen cost of exercise hyperpnea. 
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Recommendations for Further Study 
The following recommendations are made for further research on highly-trained 
endurance athletes:  
1. The present study should be repeated in highly-trained female endurance athletes. 
Previous studies show that females consistently have smaller lung volumes and lower 
maximal expiratory flow rates, even when correcting for height, when compared to 
men (McClaran, Harms, Pegelow, & Dempsey, 1998). Therefore, there is a much 
greater prevalence of FLexp in highly-trained female endurance athletes. The effect of 
FLexp on the oxygen cost of exercise hyperpnea in female endurance athletes is 
presently unknown.  
2. It appears that FLexp is a result of the ability to maximize flow during heavy to 
maximal exercise in certain individuals. There is also evidence that highly-trained 
athletes who are flow-limited during heavy to maximal exercise express a greater 
inherent drive to ventilate. Further research in this area should focus on elucidating 
the causes of differences in ventilatory drive between individuals.   
3. A study should be conducted which tests the effects of reducing flow limitation in 
highly-trained endurance athletes, who are otherwise flow-limited during maximal 
exercise, on the oxygen cost of exercise hyperpnea as well as the variables related to 
ventilatory drive.  
4. Further research on the oxygen cost of exercise hyperpnea should focus on training at 
altitude. More specifically, how does a hypoxic environment affect the oxygen cost of 
exercise hyperpnea in flow-limited athletes, who are unable to increase E during V
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maximal exercise, compared to non-flow limited athletes, who have the potential to 
increase expiratory flow rates during maximal exercise?  
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 Table 4.1 Subject Characteristics     
   Flow Limited Non-Flow Limited All Subjects  
 Age (yrs) 22.0 ± 2.7 22.2 ± 4.1 22.1 ± 3.4     
 Height (cm) 179.8 ± 4.3 179.9 ± 5.1 179.8 ± 4.6     
 Mass (kg) 67.45 ± 5.44 65.86 ± 5.81 66.66 ± 5.52     
 VO2 max (ml·kg-1·min-1) 75.72 ± 5.12 73.5 ± 5.61 74.64 ± 5.33     
 HR max (beats·min-1) 190 ± 9.6 192 ± 8.5 191 ± 8.9     
 Flow Limitation (%VT) 55.1 ± 11.3 0.3 ± 1.0 -     
 No significant differences were detected between groups (P = 0.05). Definition of terms: VO2 max, maximal     
 oxygen consumption; HR max, maximal heart rate; Flow Limitation, the percent of tidal volume that was flow      
 limited during maximal exercise. Note: Flow limitation is included in the present table for the purpose of defining     
 the separation of experimental groups. No statistical analysis was carried out on that variable.     
 
  
52 
 
            
            
 Table 4.2 Pulmonary Function Measurements    
     Flow Limited Non-Flow Limited All Subjects    
 Vital Capacity (L) 5.68 ± 0.82 5.74 ± 0.38 5.71 ± 0.62    
          %Predicted 101 ± 15.2 103 ± 0.5 102 ± 12.4    
 FEV1 (L·s-1) 4.55 ± 0.66 5.08 ± 0.52 4.82 ± 0.63    
          %Predicted 97 ± 15.2 110 ± 14 104 ± 15.5    
 FEV1/FVC (%) 81 ± 6.1 89 ± 7.6* 85 ± 7.8    
          %Predicted 97 ± 7.1 107 ± 9.1* 102 ± 9.2    
 FEF25-75 (L·s-1) 5.13 ± 0.50 7.06 ± 1.01* 6.09 ± 1.30    
          %Predicted 105 ± 12.0 147 ± 26.8*§ 126 ± 29.5    
 PEFR (L·s-1) 10.47 ± 2.25 10.75 ± 1.62 10.61 ±1.11    
          %Predicted 103 ± 21.0 107 ± 18.6 105 ± 19.4    
 *Significantly different from FL group (P < 0.05). § Actual values are significantly different from     
 predicted values (P < 0.05).    
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 Table 4.3 O2 Cost of Hyperpnea and Ventilatory Mechanics During Maximal Exercise   
     Flow Limited Non-Flow Limited All Subjects   
 VO2RM (%VO2 max) 19.19 ± 8.44 13.25 ± 4.89* 16.22 ± 7.35   
 VO2RM (ml·kg-1·min-1) 14.58 ± 6.66 9.70 ± 3.64* 12.14 ± 5.78   
 VE max (L·min-1) 176.47 ± 23.29 157.54 ± 15.31* 167.01 ± 21.46   
 VE/VO2 max 34.58 ± 3.01 32.67 ± 2.62 33.62 ± 2.91   
 VE/VCO2 max 30.52 ± 2.70 28.63 ± 1.63 29.57 ± 2.37   
 ERV (%VC) 36 ± 5.7 35 ± 6.7 36 ± 6.1   
 VT max (L·breath-1) 3.04 ± 0.41 2.96 ± 0.25 3.00 ± 0.33   
 fb max (breaths·min-1) 58.50 ± 7.19 53.56 ± 7.28 56.03 ± 7.47   
 * Significantly different from FL (P < 0.05). Definition of terms: VO2RM, respiratory muscle oxygen consumption; VE max,   
 ventilation at maximal exercise; ERV, expiratory reserve volume; VT max, average tidal volume at maximal exercise; fb max,     
 breathing frequency at maximal exercise.   
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Table 4.4 O2 Cost of Hyperpnea and Ventilatory Mechanics During Submaximal Exercise 
      Flow Limited  
Non-Flow 
Limited All Subjects 
90% of VO2 max        
 VO2RM (%VO2) 10.30 ± 7.97 7.01 ± 3.74 8.81 ± 6.35 
 VO2RM (ml·kg-1·min-1) 7.39 ± 5.96 4.52 ± 2.32 4.95 ± 5.07 
 VE (L·min-1) 142.15 ± 19.19 113.51 ± 12.40* 129.13 ± 21.66 
 VE/VO2 30.51 ± 2.90 26.15 ± 3.96 28.53 ± 3.96 
 VE/VCO2 29.88 ± 1.97 25.35 ± 2.27* 27.82 ± 3.10 
 ERV (%VC) 33 ± 7.3 32 ± 8.2 33 ± 7.3 
 VT (L·breath
-1) 2.99 ± 0.66 2.68 ± 0.25 2.99 ± 0.56 
 fb (breaths·min
-1) 49.25 ± 11.64 42.60 ± 5.50 43.27 ± 9.89 
 Flow Limitation (%VT) 39 ± 23.6 0 ± 0 - 
80% of VO2 max     
 VO2RM (%VO2) 11.95 ± 8.47 5.39 ± 3.89 8.97 ± 7.32 
 VO2RM (ml·kg-1·min-1) 7.35 ± 5.03 3.11 ± 2.23 5.42 ± 4.42 
 VE (L·min-1) 113.67 ± 18.20 92.84 ± 10.14* 104.20 ± 18.03 
 VE/VO2 27.61 ± 2.65 23.87 ± 3.32 25.91 ± 3.43 
 VE/VCO2 29.35 ± 1.97 25.28 ± 1.81* 27.50 ± 2.79 
 ERV (%VC) 32 ± 8.1 40 ± 7.7 36 ± 8.4 
 VT (L·breath
-1) 3.00 ± 0.61 2.48 ± 0.22 2.76 ± 0.53 
 fb (breaths·min
-1) 39.00 ± 8.85 37.70 ± 5.38 38.41 ± 7.16 
  Flow Limitation (%VT) 6 ± 13.9 0 ± 0 - 
* Significantly different from FL (P < 0.05). Definition of terms: VO2RM, respiratory muscle oxygen consumption; VE, exercise ventilation; 
ERV (%VC), expiratory reserve volume expressed as a percentage of vital capacity; VT, tidal volume; fb, breathing frequency. FL, n = 6; NFL, n = 5.  
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 Table 4.5  Difference in Ventilatory Mechanics Between Exercise and Voluntary Hyperpnea  
     Flow Limited Non-Flow Limited All Subjects    
 % ΔVE (L·min-1) 3.8 ± 2.7a 1.4 ± 11.1 1.2 ± 8.3a   
 ΔERV (%VC) 1.4 ± 6.0 0.5 ± 3.4 0.4 ± 4.8   
 ΔFL (%VT) 1.7 ± 9.2 4.9 ± 8.8 3.3 ± 8.9    
 a Exercise hyperpnea values are greater than voluntary hyperpnea values. Definition of terms: % ∆VE, percent difference in VE between  
 exercise and voluntary hyperpnea; ∆ERV, difference in expiratory reserve volume between exercise and voluntary hyperpnea expressed as  
 a percent of vital capacity; ∆FL, difference in flow limitation between exercise and voluntary hyperpnea expressed as a percent of tidal   
 volume.  
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Data Collection - VO2max         
Name    Post Cal      
Age             
Mass            
Height            
Pbar            
RH            
Speed            
           
  Minute Grade % HR  VO2 %VO2max ERV BF TV VE %EFL 
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Data Collection - Voluntary Hyperpnea      
Name        
Age          
Mass          
Height          
Pbar          
RH          
80% Minute VO2 VE HR ERV %EFL VE =   
              TV =   
              BF =  
              ERV =  
              %FL =  
                 
                 
         
90% Minute VO2 VE HR ERV %EFL VE =   
              TV =    
              BF =  
              ERV =  
              %FL =   
                
         
         
MAX Minute VO2 VE HR ERV %EFL VE =   
              TV =   
              BF =  
              ERV =   
              %FL =  
                
                 
              Post Cal =   
 
 
 
 
 
 
 
 
 
 
 
59 
 
 
 
 
 
 
 
 
 
APPENDIX C 
IRB Approval 
  
60 
 
 
 
61 
 
 
 
 
 
 
 
APPENDIX D 
INFORMED CONSENT, PAR-Q
62 
 
 
  
63 
 
 
 
64 
 
 
 
 
 
65 
 
 
 
 
 
 
66 
 
Modified Physical Activity Readiness Questionnaire (PAR-Q) 
Name Date 
DOB Age Home Phone Work Phone 
Regular exercise is associated with many health benefits, yet any change of activity may increase the risk of injury. 
Please read each question carefully and answer every question honestly: 
Yes No 
1. Has your doctor ever said that you have a heart condition and that you should only do physical 
activity recommended by a doctor? 
Yes No 2. Do you feel pain in your chest when you do physical activity? 
Yes No 3. In the past month, have you had chest pain when you were not doing physical activity? 
Yes No 4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
Yes No 
5. Do you have a bone or joint problem that could be made worse by a change in your physical 
activity? 
Yes No 
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or 
heart condition? 
Yes No 7. Do you know of any other reason you should to physical activity? 
Yes No 8. Has your doctor ever told you that you have diabetes?  
Yes No 9. Has your doctor ever told you that you have high blood pressure?  
Yes No 10. Has your doctor ever told you that you have high cholesterol?  
Yes No 11. Has your doctor ever told you that you have high blood sugar?  
Yes No 12. Do you smoke? 
Yes No 13. Are you currently inactive?  
Yes No 
14. Do you have a father, brother or son with heart disease before the age of 55 years old or a 
mother, sister or daughter with heart disease before the age of 65 years old? 
15. Measure height and weight to determine BMI: 
Height:________ 
Weight:________ 
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Participant Signature Date 
 
 
Note to ParQ Reader: 
 
A “yes” to any Question 1-8 will eliminate the individual from participation. 
A “yes” to 2 or more of Questions 9-14 indicates > low risk. 
#15: If over 30 kg/m2, the individual may have the risk factor of obesity. 
 
 
 
